Pediatric Cardiology

, Volume 34, Issue 8, pp 1989–1991 | Cite as

Efficacy of an Interleukin-1β Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis

  • Alessandra Scardapane
  • Antonio Brucato
  • Francesco Chiarelli
  • Luciana Breda
Case Report

Abstract

Pericarditis may recur in up to 30 % of adult patients, but recurrent pericarditis is a rare disease in childhood. The etiology of the initial attack and the causes of recurrences often remain unknown. Recurrent pericarditis is accompanied by a high morbidity rate and may represent a challenge to the clinician due to problems in management. Therapeutic strategies are not specific and include nonsteroidal antiinflammatory drugs, corticosteroids, immunosuppressive drugs, colchicine, and pericardiectomy. Controlled trials have demonstrated that colchicine can reduce the recurrent rate of pericarditis, whereas early corticosteroid therapy promotes recurrences. Anakinra, a recombinant human interleukin-1β receptor antagonist, is a promising new biologic agent for the treatment of autoinflammatory diseases such as cryopyrinopathies, tumor necrosis factor receptor-associated periodic syndrome, and hyperimmunoglobulinemia D with periodic fever syndrome. This report describes an 11-year-old boy successfully treated with anakinra for a steroid-dependent recurrent pericarditis unresponsive to conventional treatment.

Keywords

Anakinra Interleukin 1β Recurrent pericarditis 

References

  1. 1.
    Adler Y, Finkelstein Y, Guindo J, Rodriguez de la Serna A, Shoenfeld Y, Bayes-Genis A, Sagie A, Bayes de Luna A, Spodick DH (1998) Colchicine treatment for recurrent pericarditis: a decade of experience. Circulation 97:2183–2185CrossRefPubMedGoogle Scholar
  2. 2.
    Artom G, Koren-Morag N, Spodick DH, Brucato A, Guindo J, Bayes-de-Luna A, Brambilla G, Finkelstein Y, Granel B, Bayes-Genis A, Schwammenthal E, Adler Y (2005) Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multicentre all-case analysis. Eur Heart J 26:723–727CrossRefPubMedGoogle Scholar
  3. 3.
    Brucato A, Shinar Y, Brambilla G, Robbiolo L, Ferrioli G, Patrosso MC, Zanni D, Penco S, Boiani E, Ghirardello A, Caforio AL, Bergantin A, Tombini V, Moreo A, Ashtamkar L, Doria A, Shoenfeld Y, Livneh A (2005) Idiopathic recurrent pericarditis: familial Mediterranean fever mutations and disease evolution in a large cohort of caucasian patients. Lupus 14:670–674CrossRefPubMedGoogle Scholar
  4. 4.
    Brucato A, Brambilla G, Moreo A, Alberti A, Munforti C, Ghirardello A, Doria A, Shinar Y, Livneh A, Adler Y, Shoenfeld Y, Mauri F, Palmieri G, Spodick DH (2006) Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol 98:267–271CrossRefPubMedGoogle Scholar
  5. 5.
    Cantarini L, Lucherini OM, Cimaz R, Galeazzi M (2010) Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment. Clin Exp Rheumatol 28:802PubMedGoogle Scholar
  6. 6.
    Fowler NO, Harbin AD III (1986) Recurrent acute pericarditis: follow-up study of 31 patients. J Am Coll Cardiol 7:300–305CrossRefPubMedGoogle Scholar
  7. 7.
    Imazio M, Brucato A, Cemin R, Ferrua S, Belli R, Maestroni S, Trinchero R, Spodick DH, Adler Y (2011) CORP (colchicine for recurrent pericarditis) investigators colchicine for recurrent pericarditis (CORP): a randomized trial. Ann Intern Med 155:409–414CrossRefPubMedGoogle Scholar
  8. 8.
    Imazio M, Bobbio M, Cecchi E, Demarie D, Pomari F, Moratti M, Ghisio A, Belli R, Trinchero R (2005) Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (colchicine for recurrent pericarditis) trial. Arch Intern Med 165:1987–1991CrossRefPubMedGoogle Scholar
  9. 9.
    Lange RA, Hillis LD (2004) Clinical practise: acute pericarditis. N Engl J Med 351:2195–2202CrossRefPubMedGoogle Scholar
  10. 10.
    Mitroulis I, Skendros P, Ritis K (2010) Targeting IL-1β in disease: the expanding role of NLRP3 inflammasome. Eur J Intern Med 21:157–163CrossRefPubMedGoogle Scholar
  11. 11.
    Picco P, Brisca G, Traverso F, Loy A, Gattorno M, Martini A (2009) Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum 60:264–268CrossRefPubMedGoogle Scholar
  12. 12.
    Raatikka M, Pelkonen PM, Karjalainen J, Jokinen EV (2003) Recurrent pericarditis in children and adolescents. J Am Coll Cardiol 42:759–764CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Alessandra Scardapane
    • 1
  • Antonio Brucato
    • 2
  • Francesco Chiarelli
    • 1
  • Luciana Breda
    • 1
  1. 1.Department of PediatricsUniversity of ChietiChietiItaly
  2. 2.Internal Medicine Ospedali RiunitiBergamoItaly

Personalised recommendations